Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera. [PDF]
Duan M +7 more
europepmc +1 more source
Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia vera. [PDF]
Cominal JG +9 more
europepmc +1 more source
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]
Abboud, Camille N.
core +1 more source
Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera. [PDF]
Suo S +19 more
europepmc +1 more source
Progression of carotid plaque burden in patients with polycythemia vera and essential thrombocythemia. [PDF]
Kwon SS +6 more
europepmc +1 more source
Painful diabetic neuropathy complicated with secondary erythromelalgia in polycythemia vera: A case report. [PDF]
Zhang H, Qin Z, Feng X.
europepmc +1 more source
Long-term safety and effectiveness of ruxolitinib in Japanese patients with polycythemia vera: a post-marketing study. [PDF]
Hayashi T, Hongo W, Lu W.
europepmc +1 more source
Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera. [PDF]
Kaddoura R +4 more
europepmc +1 more source
Circulating Monocytes Contribute to Erythrocyte Clearance in Polycythemia Vera. [PDF]
Borges MD +9 more
europepmc +1 more source
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment [PDF]
Colagrande, M +6 more
core

